HIKAL
Back to Balance Sheet
|
HIKAL Last 5 Year Total Debt History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Debt | ₹762 Cr | ₹815 Cr | ₹748 Cr | ₹674 Cr | ₹609 Cr |
What is the latest Total Debt ratio of HIKAL ?
| Year | Total Debt |
|---|---|
| Mar2025 | ₹762 Cr |
| Mar2024 | ₹815 Cr |
| Mar2023 | ₹748 Cr |
| Mar2022 | ₹674 Cr |
| Mar2021 | ₹609 Cr |
How is Total Debt of HIKAL Trending?
| Years | Total Debt | % Change | |
|---|---|---|---|
| Mar2025 | ₹762 Cr | -6.47 | |
| Mar2024 | ₹815 Cr | 8.94 | |
| Mar2023 | ₹748 Cr | 10.90 | |
| Mar2022 | ₹674 Cr | 10.68 | |
| Mar2021 | ₹609 Cr | - | |
Compare Total Debt of peers of HIKAL
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| HIKAL | ₹2,313.1 Cr | 7.5% | 4.6% | -53.1% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹407,083.0 Cr | -1% | -7% | -1% | Stock Analytics | |
| DIVIS LABORATORIES | ₹163,971.0 Cr | 5% | -2.7% | 15.4% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹140,660.0 Cr | 3.2% | -6.2% | 29.3% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹101,686.0 Cr | 2.3% | -8.1% | 13.5% | Stock Analytics | |
| CIPLA | ₹99,086.7 Cr | 0.9% | -7.8% | -12.5% | Stock Analytics | |
HIKAL Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| HIKAL | 7.5% |
4.6% |
-53.1% |
| SENSEX | 4.7% |
-0.1% |
3.6% |
You may also like the below Video Courses